{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:43:04Z","timestamp":1792842184955,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Damietta General Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Diabetes is increasing globally, and current treatments are frequently associated with high costs and harmful side effects. Researchers are exploring safer, natural alternatives as thymoquinone and glycine. Glycine, the simplest proteinogenic amino acid, and thymoquinone, the active compound in\n                    <jats:italic>Nigella sativa<\/jats:italic>\n                    , have shown promising hypoglycemic, antioxidant, and anti-inflammatory properties. A combination of glycine and thymoquinone for treating diabetes was not investigated before. This work studies the biochemical and histopathological effects of thymoquinone and glycine administered in combination in a diabetic rat model. Diabetes mellitus was induced by streptozotocin (STZ). Five rat groups were used: control healthy, diabetes, diabetic rats treated with glycine (G) or thymoquinone (Q), or the combination (Q\u2009+\u2009G) groups. Rat body weight changes, water and food intake, fasting blood glucose (FBG), hemoglobin (Hb), glycated Hb (HbA1C), insulin, HOMA-IR, HOMA %B and HOMA %S, QUICKI, albumin, amylase, creatine kinase, TNF-\u03b1, IL-10, glucose-6-phosphatase, fructose 1,6-bisphosphatase, glucose-6-phosphat dehydrogenase, oxidative stress portrait, and pancreas histopathology were investigated. Treatment with glycine or thymoquinone or both significantly decreased FBG, oxidative stress, and inflammation and improved metabolic dysfunction compared to untreated diabetic group. It also, revealed cytoprotection to pancreas tissue and reduced inflammatory infiltration. Effects of thymoquinone and glycine treatments were appreciated, however effects of thymoquinone combined with glycine were much better. In conclusion, thymoquinone and glycine combination, can effectively reduce both blood sugar and diabetic-associated complications through their synergistic, strong antioxidant and anti-inflammatory properties, which support the body\u2019s natural cytoprotective ability.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-52735-w","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:35:12Z","timestamp":1779194112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combining glycine with thymoquinone offers a promising strategy for diabetes treatment"],"prefix":"10.1038","volume":"16","author":[{"given":"Nourhan N.","family":"Bash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6477-8098","authenticated-orcid":false,"given":"Entsar A.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim H.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kholoud H.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"1","key":"52735_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41574-024-01029-0","volume":"21","author":"A Grattoni","year":"2025","unstructured":"Grattoni, A. et al. Harnessing cellular therapeutics for type 1 diabetes mellitus: Progress, challenges, and the road ahead. Nat. Rev. Endocrinol. 21\u00a0(1), 14\u201330. https:\/\/doi.org\/10.1038\/s41574-024-01029-0 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"52735_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-075681","volume":"384","author":"S Subramanian","year":"2024","unstructured":"Subramanian, S., Khan, F. & Hirsch, I. B. New advances in type 1 diabetes. BMJ 384, e075681. https:\/\/doi.org\/10.1136\/bmj-2023-075681 (2024).","journal-title":"BMJ"},{"key":"52735_CR3","doi-asserted-by":"crossref","unstructured":"Gherbon, A. Epidemiology of Type 1 Diabetes. In Type 1 Diabetes \u2013 Causes, Treatments and Management (IntechOpen, 2025).","DOI":"10.5772\/intechopen.1009817"},{"key":"52735_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114185","volume":"148","author":"M Du","year":"2025","unstructured":"Du, M. et al. Advances in the pathogenesis and treatment strategies for type 1 diabetes mellitus. Int. Immunopharmacol. 148, 114185. https:\/\/doi.org\/10.1016\/j.intimp.2025.114185 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"52735_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mito.2023.07.002","volume":"72","author":"AV Blagov","year":"2023","unstructured":"Blagov, A. V. et al. Type 1 diabetes mellitus: Inflammation, mitophagy, and mitochondrial function. Mitochondrion 72, 11\u201321. https:\/\/doi.org\/10.1016\/j.mito.2023.07.002 (2023).","journal-title":"Mitochondrion"},{"issue":"7","key":"52735_CR6","first-page":"397","volume":"7","author":"EA Saad","year":"2015","unstructured":"Saad, E. A., Hassanien, M. M., El-hagrasy, M. A. & Radwan, K. H. Antidiabetic, hypolipidemic and antioxidant activities and protective effects of Punica granatum peels powder against pancreatic and hepatic tissues injuries in streptozotocin induced IDDM in rats. Int. J. Pharm. Pharm. Sci. 7\u00a0(7), 397\u2013402 (2015).","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"52735_CR7","first-page":"265","volume":"139","author":"EA Saad","year":"2013","unstructured":"Saad, E. A. & Habib, S. A. Effect of crude extracts of some medicinal plants on the osmotic stability of human erythrocytes in vitro. J. Free Rad. Antiox. Photon. 139, 265\u2013272 (2013).","journal-title":"J. Free Rad. Antiox. Photon."},{"issue":"2","key":"52735_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.12991\/jrespharm.1664922","volume":"29","author":"FE Abdlsamea","year":"2025","unstructured":"Abdlsamea, F. E., Zahran, R. F. & Saad, E. A. Proanthocyanidin: An interesting option as cisplatin-alternative in solid tumor treatment. J. Res. Pharm. 29\u00a0(2), 751\u2013763. https:\/\/doi.org\/10.12991\/jrespharm.1664922 (2025).","journal-title":"J. Res. Pharm."},{"issue":"6","key":"52735_CR9","first-page":"72","volume":"7","author":"EA Saad","year":"2015","unstructured":"Saad, E. A., Toson, E. A. & Ahmed, G. M. Clove or green tea administration antagonizes khat hepatotoxicity in rats. Int. J. Pharm. Pharm. Sci. 7\u00a0(6), 72\u201376 (2015).","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"52735_CR10","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4103\/pm.pm_271_18","volume":"14","author":"EA Saad","year":"2018","unstructured":"Saad, E. A., El-Gayar, H. A., El-Demerdash, R. S. & Radwan, K. H. Frankincense administration antagonizes adenine-induced chronic renal failure in rats. Phcog. Mag. 14, 634\u2013640. https:\/\/doi.org\/10.4103\/pm.pm_271_18 (2018).","journal-title":"Phcog. Mag."},{"issue":"2","key":"52735_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40268-024-00479-1","volume":"24","author":"NM El Ezaby","year":"2024","unstructured":"El Ezaby, N. M., Saad, E. A. & El Basuni, M. A. Acetylsalicylic acid with ascorbate: A promising combination therapy for solid tumors. Drugs R. D. 24\u00a0(2), 303\u2013316. https:\/\/doi.org\/10.1007\/s40268-024-00479-1 (2024).","journal-title":"Drugs R. D."},{"issue":"1","key":"52735_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10644-5","volume":"23","author":"RR El Sadda","year":"2023","unstructured":"El Sadda, R. R., Elshahawy, Z. R. & Saad, E. A. Biochemical and pathophysiological improvements in rats with thioacetamide induced-hepatocellular carcinoma using aspirin plus vitamin C. BMC Cancer 23\u00a0(1), 175. https:\/\/doi.org\/10.1186\/s12885-023-10644-5 (2023).","journal-title":"BMC Cancer"},{"key":"52735_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1126272","volume":"10","author":"A Shaukat","year":"2023","unstructured":"Shaukat, A., Zaidi, A., Anwar, H. & Kizilbash, N. Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: A review. Front. Nutr. 10, Article 1126272. https:\/\/doi.org\/10.3389\/fnut.2023.1126272 (2023).","journal-title":"Front. Nutr."},{"key":"52735_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-023-03847-x","volume":"14","author":"K Ramineedu","year":"2024","unstructured":"Ramineedu, K. et al. Thymoquinone mitigates obesity and diabetic parameters through regulation of major adipokines, key lipid metabolizing enzymes and AMPK\/p-AMPK in diet-induced obese rats. 3 Biotech 14, 16 (2024).","journal-title":"3 Biotech"},{"key":"52735_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62780-y","volume":"14","author":"MH Hafez","year":"2024","unstructured":"Hafez, M. H., Ez Elarab, S. M., Tohamy, H. G. & El-Far, A. H. Thymoquinone attenuates diabetes-induced hepatic damage in rat via regulation of oxidative\/nitrosative stress, apoptosis, and inflammatory cascade with molecular docking approach. Sci. Rep. 14, 13016 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"52735_CR16","first-page":"497","volume":"48","author":"KM Mohany","year":"2025","unstructured":"Mohany, K. M., Othman, A., Refaiy, A., Fathy, O. & El-Deek, S. E. M. Curcumin, thymoquinone, and metformin: Impact on serum levels of AGEs, SDF-1, miR-192 and miR-497, and hepatic oxidative stress and G6PD expression in diabetic rats. Bull. Pharm. Sci. 48 (1), 497\u2013510 (2025).","journal-title":"Bull. Pharm. Sci."},{"issue":"8","key":"52735_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26082348","volume":"26","author":"M Faisal Lutfi","year":"2021","unstructured":"Faisal Lutfi, M. et al. Thymoquinone lowers blood glucose and reduces oxidative stress in a rat model of diabetes. Molecules 26\u00a0(8), 2348. https:\/\/doi.org\/10.3390\/molecules26082348 (2021).","journal-title":"Molecules"},{"issue":"6","key":"52735_CR18","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1007\/s12011-022-03399-w","volume":"201","author":"B Salama","year":"2023","unstructured":"Salama, B. et al. Silver nanoparticles enhance oxidative stress, inflammation, and apoptosis in liver and kidney tissues: Potential protective role of thymoquinone. Biol. Trace Elem. Res. 201\u00a0(6), 2942\u20132954. https:\/\/doi.org\/10.1007\/s12011-022-03399-w (2023).","journal-title":"Biol. Trace Elem. Res."},{"issue":"1","key":"52735_CR19","first-page":"209","volume":"19","author":"SP Lee","year":"2023","unstructured":"Lee, S. P., Kuo, F. Y., Cheng, J. T. & Wu, M. C. Thymoquinone activates imidazoline receptor to enhance glucagon-like peptide-1 secretion in diabetic rats. Arch. Med. Sci. 19 (1), 209\u2013215 (2023).","journal-title":"Arch. Med. Sci."},{"issue":"5","key":"52735_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40618-021-01720-3","volume":"45","author":"M Imenshahidi","year":"2022","unstructured":"Imenshahidi, M. & Hossenzadeh, H. Effects of glycine on metabolic syndrome components: A review. J. Endocrinol. Invest. 45\u00a0(5), 927\u2013939 (2022).","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"52735_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00726-023-03261-w","volume":"55","author":"MI Shosha","year":"2023","unstructured":"Shosha, M. I., El-Ablack, F. Z. & Saad, E. A. Glycine protects against doxorubicin-induced heart toxicity in mice. Amino Acids 55\u00a0(5), 679\u2013693. https:\/\/doi.org\/10.1007\/s00726-023-03261-w (2023).","journal-title":"Amino Acids"},{"issue":"1","key":"52735_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/antiox11010154","volume":"11","author":"RV Sekhar","year":"2022","unstructured":"Sekhar, R. V. GlyNAC (Glycine and N-Acetylcysteine) supplementation improves impaired mitochondrial fuel oxidation and lowers insulin resistance in patients with Type 2 Diabetes: Results of a pilot study. Antioxidants 11\u00a0(1), 154 (2022).","journal-title":"Antioxidants"},{"issue":"Supplement_1","key":"52735_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2337\/db22-348-OR","volume":"71","author":"H El Ayash","year":"2022","unstructured":"El Ayash, H. et al. Glycine and branched-chain amino acids (BCAA) metabolic signature in youth with obesity and type 2 diabetes (T2D). Diabetes 71\u00a0(Supplement_1), 348-OR (2022).","journal-title":"Diabetes"},{"key":"52735_CR24","doi-asserted-by":"publisher","first-page":"104617","DOI":"10.1016\/j.mvr.2023.104617","volume":"151","author":"B Wang","year":"2024","unstructured":"Wang, B. et al. Harnessing the benefits of glycine supplementation for improved pancreatic microcirculation in type 1 diabetes mellitus. Microvasc Res. 151, 104617. https:\/\/doi.org\/10.1016\/j.mvr.2023.104617 (2024).","journal-title":"Microvasc Res."},{"issue":"14","key":"52735_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411236","volume":"24","author":"KA Aguayo-Cer\u00f3n","year":"2023","unstructured":"Aguayo-Cer\u00f3n, K. A. et al. Glycine: The smallest anti-inflammatory micronutrient. Int. J. Mol. Sci. 24\u00a0(14), 11236 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"52735_CR26","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/healthcare12151485","volume":"12","author":"RAA Salama","year":"2024","unstructured":"Salama, R. A. A., Patni, M. A. M. F., Ba-Hutair, S. N. M., Wadid, N. A. & Akikwala, M. S. Exploring novel treatment modalities for Type 1 Diabetes Mellitus: Potential and prospects. Healthc. (Basel) 12\u00a0(15), 1485. https:\/\/doi.org\/10.3390\/healthcare12151485 (2024).","journal-title":"Healthc. (Basel)"},{"key":"52735_CR27","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz, A. et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85, 2402\u20132410 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"52735_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.22159\/ijpps.2017v9i10.21149","volume":"9","author":"EA Saad","year":"2017","unstructured":"Saad, E. A., Habib, S. A., Refai, W. A. & Elfayoumy, A. A. Malondialdehyde, adiponectin, nitric oxide, C-reactive protein, tumor necrosis factor-alpha and insulin resistance relationships and inter-relationships in Type 2 Diabetes early stage. Is metformin alone adequate in this stage?. Int. J. Pharm. Pharm. Sci. 9, 176\u2013181 (2017).","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"52735_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2147\/DMSO.S207596","volume":"12","author":"SP Lee","year":"2019","unstructured":"Lee, S. P., Kuo, F. Y., Cheng, J. T. & Wu, M. C. GLP-1 mediates the modulating effect of thymoquinone on feeding behaviors in diabetic rats. Diabetes Metab. Syndr. Obes. Targets Ther. 12, 873\u2013881. https:\/\/doi.org\/10.2147\/DMSO.S207596 (2019).","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"52735_CR30","doi-asserted-by":"publisher","unstructured":"Wang, L. et al. State-dependent central synaptic regulation by GLP-1 is essential for energy homeostasis. Res. Sq. [Preprint]. Mar 12:rs.3.rs-3929981. (2024). https:\/\/doi.org\/10.21203\/rs.3.rs-3929981\/v1. Update in: Nat. Metab. 7 (7), 1443\u20131458 (2025). Doi: 10.1038\/s42255-025-01305-x.","DOI":"10.21203\/rs.3.rs-3929981\/v1"},{"issue":"20","key":"52735_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012111","volume":"23","author":"MF Mahomoodally","year":"2022","unstructured":"Mahomoodally, M. F., Aumeeruddy, M. Z., Legoabe, L. J., Montesano, D. & Zengin, G. Nigella sativa L. and its active compound thymoquinone in the clinical management of diabetes: A systematic review. Int. J. Mol. Sci. 23\u00a0(20), 12111 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"52735_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/DMSO.S82272","volume":"8","author":"J Wu","year":"2015","unstructured":"Wu, J. & Yan, L. J. Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic \u03b2 cell glucotoxicity. Diabetes Metab. Syndr. Obes. Targets Ther. 8, 181. https:\/\/doi.org\/10.2147\/DMSO.S82272 (2015).","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"52735_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fendo.2013.00037","volume":"4","author":"ME Cerf","year":"2013","unstructured":"Cerf, M. E. Beta cell dysfunction and insulin resistance. Front. Endocrinol. 4, 37. https:\/\/doi.org\/10.3389\/fendo.2013.00037 (2013).","journal-title":"Front. Endocrinol."},{"key":"52735_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2101562","volume":"2018","author":"M El-Hafidi","year":"2018","unstructured":"El-Hafidi, M. et al. Glycine increases insulin sensitivity and glutathione biosynthesis and protects against oxidative stress in a model of sucrose-induced insulin resistance. Oxid. Med. Cell. Longev. 2018, 2101562. https:\/\/doi.org\/10.1155\/2018\/2101562 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"52735_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003680","volume":"12","author":"H Hu","year":"2024","unstructured":"Hu, H., Nakagawa, T., Honda, T., Yamamoto, S. & Mizoue, T. Should insulin resistance (HOMA-IR), insulin secretion (HOMA-\u03b2), and visceral fat area be considered for improving the performance of diabetes risk prediction models?. BMJ Open Diabetes Res. Care. 12\u00a0(1), e003680 (2024).","journal-title":"BMJ Open Diabetes Res. Care."},{"issue":"1","key":"52735_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12902-023-01291-9","volume":"23","author":"D Khalili","year":"2023","unstructured":"Khalili, D. et al. Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?. BMC Endocr. Disord. 23\u00a0(1), 39 (2023).","journal-title":"BMC Endocr. Disord."},{"key":"52735_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1294290","volume":"11","author":"GM Bambo","year":"2024","unstructured":"Bambo, G. M. et al. Changes in selected hematological parameters in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis. Front. Med. 11, Article 1294290 (2024).","journal-title":"Front. Med."},{"key":"52735_CR38","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2147\/DMSO.S350426","volume":"15","author":"JY Wan","year":"2022","unstructured":"Wan, J. Y. & Yang, L. Z. Liver enzymes are associated with hyperglycemia in diabetes: A three-year retrospective study. Diabetes Metab. Syndr. Obes. Targets Ther. 15, 545\u2013555 (2022).","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"52735_CR39","volume":"115","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y., Wang, L., Zhang, H. & Li, X. Glycine supplementation improves lipid metabolism and antioxidant status in diabetic models: A mechanistic insight into pancreatic enzyme regulation. J. Nutr. Biochem. 115, Article 109234 (2024).","journal-title":"J. Nutr. Biochem."},{"key":"52735_CR40","unstructured":"Kinjir, H. et al. The role of lipid peroxidation and antioxidant therapies in the management of diabetes and hypertension. Innov. Res. Biotechnol. 4 (1) (2025)."},{"key":"52735_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2021.104544","volume":"83","author":"F Alvarado","year":"2021","unstructured":"Alvarado, F., Garza, R., Rodr\u00edguez, A. & Morales, J. Glycine supplementation attenuates oxidative stress, improves renal function, and preserves serum albumin levels in streptozotocin-induced diabetic rats. J. Funct. Foods 83, 104544. https:\/\/doi.org\/10.1016\/j.jff.2021.104544 (2021).","journal-title":"J. Funct. Foods"},{"issue":"1","key":"52735_CR42","first-page":"103","volume":"2","author":"NH Al-Fahadi","year":"2025","unstructured":"Al-Fahadi, N. H., Saleh, S. G. & Al-Ghadhanfari, E. M. T. Glycine level in GOT, GPT enzyme activity, and its relationship to heart disease. Indones. J. Health Sci. Med. 2\u00a0(1), 103\u2013112 (2025).","journal-title":"Indones. J. Health Sci. Med."},{"key":"52735_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1340604","volume":"15","author":"Y Bi","year":"2024","unstructured":"Bi, Y. et al. Association between liver enzymes and type 2 diabetes: A real-world study. Front. Endocrinol. 15, Article 1340604 (2024).","journal-title":"Front. Endocrinol."},{"issue":"6","key":"52735_CR44","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/HYPERTENSIONAHA.123.22649","volume":"81","author":"M Dziedzic","year":"2024","unstructured":"Dziedzic, M., J\u00f3zefczuk, E., Guzik, T. J. & Siedlinski, M. Interplay between plasma glycine and branched-chain amino acids contributes to the development of hypertension and coronary heart disease. Hypertension 81 (6), 1320\u20131331 (2024).","journal-title":"Hypertension"},{"issue":"4","key":"52735_CR45","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.3892\/mmr.2016.4823","volume":"13","author":"H Liu","year":"2016","unstructured":"Liu, H., Liu, H. Y., Jiang, Y. N. & Li, N. Protective effect of thymoquinone improves cardiovascular function, and attenuates oxidative stress, inflammation and apoptosis by mediating the PI3K\/Akt pathway in diabetic rats. Mol. Med. Rep. 13 (4), 2836\u20132842 (2016).","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"52735_CR46","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00210-021-02095-1","volume":"394","author":"AA Hafez","year":"2021","unstructured":"Hafez, A. A., Jamali, Z., Khezri, S. & Salimi, A. Thymoquinone reduces mitochondrial damage and death of cardiomyocytes induced by clozapine. Naunyn Schmiedebergs Arch. Pharmacol. 394 (8), 1675\u20131684. https:\/\/doi.org\/10.1007\/s00210-021-02095-1 (2021).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"52735_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04725-4","author":"SS Eldebsy","year":"2026","unstructured":"Eldebsy, S. S., Saad, E. A. & El Sadda, R. R. Optimized renal protection with combined thymoquinone and glycine treatment: Synergistic management of streptozotocin-induced nephropathy. Naunyn Schmiedebergs Arch. Pharmacol.\u00a0399 (4), 5621\u20135632.\u00a0https:\/\/doi.org\/10.1007\/s00210-025-04725-4 (2026).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"14","key":"52735_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411236","volume":"24","author":"KA Aguayo-Cer\u00f3n","year":"2023","unstructured":"Aguayo-Cer\u00f3n, K. A. et al. Glycine: The smallest anti-inflammatory micronutrient. Int. J. Mol. Sci. 24\u00a0(14), 11236. https:\/\/doi.org\/10.3390\/ijms241411236 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"52735_CR49","volume":"70","author":"Z Hadj Ali","year":"2020","unstructured":"Hadj Ali, Z. et al. Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: About a case report. Endocr. Abstr. 70, AEP442 (2020).","journal-title":"Endocr. Abstr."},{"key":"52735_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.932154","volume":"13","author":"Q Meng","year":"2022","unstructured":"Meng, Q. et al. Recent findings in the regulation of G6PD and its role in diseases. Front. Pharmacol. 13, 932154 (2022).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"52735_CR51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12902-021-00911-6","volume":"21","author":"NS Karadsheh","year":"2021","unstructured":"Karadsheh, N. S., Quttaineh, N. A., Karadsheh, S. N. & El-Khateeb, M. Effect of combined G6PD deficiency and diabetes on protein oxidation and lipid peroxidation. BMC Endocr. Disorders. 21 (1), 246 (2021).","journal-title":"BMC Endocr. Disorders"},{"key":"52735_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1126272","volume":"10","author":"A Shaukat","year":"2023","unstructured":"Shaukat, A. et al. Thymoquinone ameliorates glucose intolerance and hepatic gluconeogenesis via modulation of insulin signaling pathways in diabetic rats. Front. Nutr. 10, 1126272 (2023).","journal-title":"Front. Nutr."},{"issue":"6","key":"52735_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/nu11061356","volume":"11","author":"MM Adeva-Andany","year":"2019","unstructured":"Adeva-Andany, M. M. et al. Glycine metabolism and its alterations in obesity and metabolic diseases. Nutrients 11\u00a0(6), 1356. https:\/\/doi.org\/10.3390\/nu11061356 (2019).","journal-title":"Nutrients"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52735-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52735-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:55:09Z","timestamp":1779195309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52735-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52735"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52735-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments comply with the ARRIVE guidelines and are carried out in accordance with the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health and approved by the Chemistry Department, Faculty of Science, Damietta University, Damietta, Egypt (Board No. 207).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"15504"}}